The launch of a code of conduct restricting pharmaceutical companies from corrupting doctors and other healthcare personnel is a move in the right direction, even though it is long overdue.
It has become common practice for pharmaceutical companies to unduly influence health personnel to prescribe their drugs even when these are prohibitively expensive-- just to make a profit.
